
DBCO-C6-NHS ester | CAS 1384870-47-6
| Catalog Number | R01-0024 | 
| Category | NHS Esters | 
| Molecular Formula | C25H22N2O5 | 
| Molecular Weight | 430.46 | 
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Product Introduction
DBCO-C6-NHS ester is a click-ready ADC linker combining a DBCO group for copper-free conjugation with an NHS ester for amine coupling. Suitable for site-selective antibody labeling in the development of stable antibody-drug conjugates.
Chemical Information
Product Specification
Computed Properties
Patents
| Synonyms | DBCO NHS ester;DBCO-NHS ester 2; Azadibenzocyclooctyne-NHS ester; DBCO-(CH2)2-NH2-CO-(CH2)4COOH-NHS | 
| Purity | NMR 1H, HPLC-MS (95%) | 
| IUPAC Name | |
| Canonical SMILES | C1CC(=O)N(C1=O)OC(=O)CCCCC(=O)N2CC3=CC=CC=C3C#CC4=CC=CC=C42 | 
| InChI | InChI=1S/C25H22N2O5/c28-22(11-5-6-12-25(31)32-27-23(29)15-16-24(27)30)26-17-20-9-2-1-7-18(20)13-14-19-8-3-4-10-21(19)26/h1-4,7-10H,5-6,11-12,15-17H2 | 
| InChIKey | CATTUKBAYDNTEG-UHFFFAOYSA-N | 
| Solubility | good in DCM, DMF, DMSO | 
| Density | 1.37±0.1 g/cm3 | 
| Appearance | off-white solid | 
| Boiling Point | 685.5±65.0 °C at 760 mmHg | 
| Storage | 12 months after receival at -20°C in the dark. Transportation: at room temperature for up to 3 weeks. Avoid prolonged exposure to light. Desiccate. | 
| XLogP3 | 2.5 | 
| Hydrogen Bond Donor Count | 0 | 
| Hydrogen Bond Acceptor Count | 5 | 
| Rotatable Bond Count | 7 | 
| Exact Mass | 430.15287181 g/mol | 
| Monoisotopic Mass | 430.15287181 g/mol | 
| Topological Polar Surface Area | 84Ų | 
| Heavy Atom Count | 32 | 
| Formal Charge | 0 | 
| Complexity | 809 | 
| Isotope Atom Count | 0 | 
| Defined Atom Stereocenter Count | 0 | 
| Undefined Atom Stereocenter Count | 0 | 
| Defined Bond Stereocenter Count | 0 | 
| Undefined Bond Stereocenter Count | 0 | 
| Covalently-Bonded Unit Count | 1 | 
| Compound Is Canonicalized | Yes | 
| Publication Number | Title | Priority Date | 
|---|---|---|
| WO-2022263944-A1 | Azido-containing monomers, polymers, and articles | 2021-06-16 | 
| WO-2021178818-A2 | Therapeutic agents and conjugates thereof | 2020-03-06 | 
| US-2022280598-A1 | Complement inhibitor dosing regimens | 2019-07-18 | 
| US-2022249706-A1 | Viral vector therapy | 2019-07-05 | 
| WO-2020229982-A1 | Antibody drug conjugates | 2019-05-10 | 
Recommended Services
Recommended Articles
        - Hoechst Dyes: Definition, Structure, Mechanism and Applications
 - Mastering the Spectrum: A Comprehensive Guide to Cy3 and Cy5 Dyes
 - Fluorescent Probes: Definition, Structure, Types and Application
 - Fluorescent Dyes: Definition, Mechanism, Types and Application
 - Coumarin Dyes: Definition, Structure, Benefits, Synthesis and Uses
 - BODIPY Dyes: Definition, Structure, Synthesis and Uses
 - Cyanine Dyes: Definition, Structure, Types and Uses
 - Fluorescein Dyes: Definition, Structure, Synthesis and Uses
 - Rhodamine Dyes: Definition, Structure, Uses, Excitation and Emission
 
- Unlocking the Power of Fluorescence Imaging: A Comprehensive Guide
 - Cell Imaging: Definitions, Systems, Protocols, Dyes, and Applications
 - Lipid Staining: Definition, Principles, Methods, Dyes, and Uses
 - Flow Cytometry: Definition, Principles, Protocols, Dyes, and Uses
 - Nucleic Acid Staining: Definition, Principles, Dyes, Procedures, and Uses
 - DNA Staining: Definition, Procedures, Benefits, Dyes and Uses
 - Cell Staining: Definition, Principles, Protocols, Dyes, and Uses
 - Ion Imaging: Definition, Principles, Benefits, Dyes, and Uses
 - Fluorescent Labeling: Definition, Principles, Types and Applications
 
Recommended Products
Online Inquiry